Skip to main content


NCCN Annual Conference 2019

April 02, 2019

The National Comprehensive Cancer Network (NCCN) Annual Conference was held on March 21-23, 2019 in Orlando, FL. Over 1650 community and academic oncologists, oncology fellows, nurses, pharmacists, and other health care professionals gathered to view and discuss research related to the latest cancer therapies as well as provide updated on selected NCCN Clinical Practice Guidelines in Oncology.

Journal of Clinical Pathways attended the meeting to provide coverage of some of the most pertinent sessions.

Update on Biosimilars in Oncology: Clinical Concerns, Market Developments

Gary H Lyman, MD, MPH, discussed biosimilars in oncology care, providing an overview of what biosimilars are, an update on new developments, and a forecast of how biosimilars may impact cancer costs and treatment. 

Read More


The Patient Journey When Receiving Innovative Therapy: Improving Care in Real Time

A session focused on how early experiences of CAR-T therapy delivery have shaped improved processes surrounding the therapy and implications for other innovative agents. 

Read More


Screening for Distress in Cancer: Implementing the Standard of Care

Michelle B Riba, MD, MS, discussed the prevalence of distress in patients with cancer and its potential impact on medical management, as well as strategies for improving integration of psychosocial care into routine care of patients with cancer.

Read More


Care Coordination for Cancer Survivors: Collaboration With Primary Care Teams

Carlin Callaway, DNP, RN, and Linda Overholser, MD, MPH, discussed the importance of care coordination between primary care providers, oncologists, and other specialists, as well as ways to facilitate enhanced care coordination, including utilization of survivorship care plans. 

Read More

Back to Top